Published in Dis Colon Rectum on March 01, 2012
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol (2012) 1.37
Lymph node staging in colorectal cancer: old controversies and recent advances. World J Gastroenterol (2013) 1.01
Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series. Front Oncol (2014) 0.99
Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma. Arch Pathol Lab Med (2013) 0.92
Possible biological and translational significance of mast cells density in colorectal cancer. World J Gastroenterol (2014) 0.92
The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg (2013) 0.90
Laparoscopic rectal cancer surgery: where do we stand? World J Gastroenterol (2012) 0.86
Laparoscopic versus open resection for colon cancer: 10-year outcomes of a prospective clinical trial. Surg Endosc (2014) 0.85
Is the lymph node ratio superior to the Union for International Cancer Control (UICC) TNM system in prognosis of colon cancer? World J Surg Oncol (2013) 0.84
Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection. Br J Cancer (2015) 0.83
Assessment of lymph node involvement in colorectal cancer. World J Gastrointest Surg (2016) 0.82
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center. J Cancer Res Clin Oncol (2014) 0.81
Increased lymph node yield in colorectal cancer is not necessarily associated with a greater number of lymph node positive cancers. PLoS One (2014) 0.80
Extended lymphadenectomy in colon cancer is debatable. World J Surg (2013) 0.78
Short- and long-term outcomes for patients with splenic flexure tumours treated by left versus extended right colectomy are comparable: a retrospective analysis. Surg Today (2013) 0.77
High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population. Int Sch Res Notices (2015) 0.75
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol (2017) 0.75
Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery. Int J Mol Sci (2016) 0.75
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol (2017) 0.75
A nomogram improves AJCC stages for colorectal cancers by introducing CEA, modified lymph node ratio and negative lymph node count. Sci Rep (2016) 0.75
A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer. PLoS One (2016) 0.75
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75
Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer. Tech Coloproctol (2014) 0.75
The positive impact of surgical quality control on adequate lymph node harvest by standardized laparoscopic surgery and national quality assessment program in colorectal cancer. Int J Colorectal Dis (2017) 0.75
Extended lymphadenectomy in colon cancer is crucial. World J Surg (2013) 0.75
Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol (2009) 2.08
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut (2012) 1.63
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome. Int J Cancer (2011) 1.39
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia (2012) 1.39
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int (2008) 1.37
O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res (2013) 1.31
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One (2010) 1.26
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer (2011) 1.22
Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene (2005) 1.22
UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy. Autophagy (2010) 1.16
Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival. Genome Med (2011) 1.13
ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. Clin Cancer Res (2012) 1.11
Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer. Dis Colon Rectum (2011) 1.07
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci. Mol Cancer (2010) 1.01
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer. Mol Cancer (2011) 1.00
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial. Nutr Cancer (2011) 0.99
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome. PLoS One (2011) 0.94
Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients. Age Ageing (2010) 0.89
Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study. Surg Endosc (2011) 0.88
Androgen dependent regulation of protein kinase A subunits in prostate cancer cells. Cell Signal (2006) 0.88
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers. Int J Cancer (2014) 0.86
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome. BMC Cancer (2014) 0.86
Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors. J Surg Oncol (2011) 0.86
Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet. Atherosclerosis (2002) 0.86
Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. Mod Pathol (2006) 0.86
Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract. Scand J Gastroenterol (2012) 0.86
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. Clin Transl Gastroenterol (2012) 0.85
Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: is Godot finally arriving? Clin Cancer Res (2013) 0.85
Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer. Dis Colon Rectum (2008) 0.83
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer. World J Urol (2014) 0.83
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer. Int J Cancer (2012) 0.83
Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice. Am J Physiol Heart Circ Physiol (2006) 0.82
A novel transcript, VNN1-AB, as a biomarker for colorectal cancer. Int J Cancer (2014) 0.82
Establishing laparoscopic Roux-en-Y gastric bypass: perioperative outcome and characteristics of the learning curve. Obes Surg (2008) 0.82
The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy. Br J Nutr (2012) 0.81
Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing. Transl Oncol (2013) 0.81
Distribution of neuropeptide Y Y1 and Y2 receptors in the postmortem human heart. Peptides (2003) 0.81
Preoperative staging and treatment options in T1 rectal adenocarcinoma. Acta Oncol (2009) 0.80
[Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]. Tidsskr Nor Laegeforen (2008) 0.79
Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans. Diab Vasc Dis Res (2011) 0.78
Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer. Scand J Urol Nephrol (2011) 0.77
Activity of peroxisomal enzymes, and levels of polyamines in LPA-transgenic mice on two different diets. Lipids Health Dis (2005) 0.77
[Colorectal polyps]. Tidsskr Nor Laegeforen (2007) 0.76
National Early Rectal Cancer Treatment Revisited. Dis Colon Rectum (2016) 0.76
[Markers for diagnosis, prediction and prognosis of prostate cancer]. Tidsskr Nor Laegeforen (2005) 0.76
[Surgical treatment of morbid obesity at a regional center]. Tidsskr Nor Laegeforen (2007) 0.75
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study. Scand J Urol (2012) 0.75
Atherogenesis and vascular calcification in mice expressing the human LPA gene. Pathophysiology (2004) 0.75
[Pilonidal disease--an underprioritized disorder]. Tidsskr Nor Laegeforen (2010) 0.75